We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
EKTA-B.ST

Price
48.28
Stock movement up
+1.40 (2.99%)
Company name
Elekta AB (publ)
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Medical Devices
Market cap
17.72B
Ent value
36.44B
Price/Sales
1.00
Price/Book
1.69
Div yield
-
Div growth
-
Growth years
-
FCF payout
157.39%
Trailing P/E
17.69
Forward P/E
10.12
PEG
-
EPS growth
1.68%
1 year return
-38.65%
3 year return
-12.35%
5 year return
-10.90%
10 year return
-4.92%
Last updated: 2025-04-15

DIVIDENDS

EKTA-B.ST does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E17.69
Price to OCF7.54
Price to FCF30.45
Price to EBITDA6.42
EV to EBITDA13.19

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1.00
Price to Book1.69
EV to Sales2.06

FINANCIALS

Per share

Loading...
Per share data
Current share count367.10M
EPS (TTM)2.60
FCF per share (TTM)1.51

Income statement

Loading...
Income statement data
Revenue (TTM)17.73B
Gross profit (TTM)6.45B
Operating income (TTM)1.90B
Net income (TTM)1.00B
EPS (TTM)2.60
EPS (1y forward)4.77

Margins

Loading...
Margins data
Gross margin (TTM)36.40%
Operating margin (TTM)10.70%
Profit margin (TTM)5.65%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash3.35B
Net receivables0.00
Total current assets14.77B
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets32.53B
Accounts payable1.66B
Short/Current long term debt9.29B
Total current liabilities14.02B
Total liabilities22.07B
Shareholder's equity10.47B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)2.35B
Capital expenditures (TTM)1.77B
Free cash flow (TTM)582.00M
Dividends paid (TTM)916.00M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity9.57%
Return on Assets3.08%
Return on Invested Capital8.07%
Cash Return on Invested Capital4.68%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open48.30
Daily high48.30
Daily low47.74
Daily Volume1.81M
All-time high143.00
1y analyst estimate73.81
Beta1.12
EPS (TTM)2.60
Dividend per share-
Ex-div date6 Mar 2025
Next earnings date3 Jun 2025

Downside potential

Loading...
Downside potential data
EKTA-B.STS&P500
Current price drop from All-time high-66.24%-12.04%
Highest price drop-92.22%-56.47%
Date of highest drop25 Aug 20009 Mar 2009
Avg drop from high-32.29%-11.07%
Avg time to new high36 days12 days
Max time to new high2337 days1805 days
COMPANY DETAILS
EKTA-B.ST (Elekta AB (publ)) company logo
Marketcap
17.72B
Marketcap category
Large-cap
Description
Elekta AB (publ), a medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. The company offers radiation therapy products, including Elekta Unity for real-time MR visualization; Elekta Versa HD, a brain metastases solution; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; and quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit; Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Leksell GammaPlan, a treatment planning and management software. In addition, the company offers Elekta ONE, a software suite of multiple Elekta solutions. Further, it provides brachytherapy products, including Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Elekta Xoft Axxent, and electronic brachytherapy systems; Elekta Geneva, an applicator for cervical cancer patients; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Venezia applicator that enables the oncologist to treat locally advanced cervical cancer. Additionally, the company offers neurosurgery products, such as Leksell Vantage Stereotactic System for intracranial neurosurgery. Furthermore, it provides Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
Employees
4566
Investor relations
-
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found